Descrizione
Integratore alimentare a base di di Hericium titolato al 50% in polisaccaridi e al 20% inbeta(1,3-1,6)-D-glucani, da agricoltura biologica. Adatto a vegani, DNA certificato,doping free.

Ingredienti
Hericium erinaceus sporoforo%; capsula di origine vegetale inidrossipropilmetilcellulosa.
%Ingrediente biologico.

Senza glutine.

Caratteristiche nutrizionali

Valori medi per 2 capsule
Hericium erinaceus(Bull.) Pers% sporoforo polvere titolata 50% polisaccaridi totali 20% beta(1,3-1,6)-D-glucani	1.000 mg 500 mg 200 mg
Capsula di origine vegetale inidrossipropilmetilcellulosa

Modalità d’uso
Assumere 1 capsula due volte al giorno durante i pasti.

Avvertenze
Non eccedere la dose giornaliera raccomandata.
Tenere fuori dalla portata dei bambini al di sotto dei 3 anni di età.
Gli integratori non vanno intesi come sostituti di una dieta variata e vanno utilizzatiseguendo uno stile di vita sano ed equilibrato.

Conservazione
Conservare in luogo fresco ed asciutto.
Validità a confezionamento integro: 36 mesi.

Formato
Flacone contenente 60 capsule da 0,600 g.
Peso netto: 36 g.

Cod. 0419

Bibliografia
-Phan CW et al., Hericium erinaceus (Bull.: Fr) Pers. cultivated under tropicalconditions: isolation of hericenones and demonstration of NGF-mediated neurite outgrowthin PC12 cells via MEK/ERK and PI3K-Akt signaling pathways, Food Funct. 2014Dec;5(12):3160-9.
-Lee KF et al., Protective effects of Hericium erinaceus mycelium and its isolatederinacine A against ischemia-injury- induced neuronal cell death via the inhibition ofiNOS/p38 MAPK and nitrotyrosine, Int J Mol Sci. 2014 Aug 27;15 (9):15073-89.
-Jiang S et al., Medicinal properties of Hericium erinaceus and its potential toformulate novel mushroom-based pharmaceuticals, Appl Microbiol Biotechnol. 2014Sep;98(18):7661-70.
-Zhu Y et al., Preparation, characterization, and anti-Helicobacter pylori activity ofBi3+-Hericium erinaceus polysaccharide complex, Carbohydr Polym. 2014 Sep 22;110:231.
-Xinyi Zan et al., Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cellgrowth via cell cycle arrest and apoptosis, International Journal of BiologicalMacromolecules, 2015, 76, 242-253. Liu Z, et al., Systemic Screening of Strains of theLion’s Mane Medicinal Mushroom Hericium erinaceus(Higher Basidiomycetes) and ItsProtective Effects on A-Triggered.
-Neurotoxicity in PC12 Cells, Int J Med Mushrooms. 2015;17(3):219-29.
-Zhang Yi et al., Protective Effect of Ethanol Extracts of Hericium erinaceus on Alloxan-Induced Diabetic Neuropathic Pain in Rats, Evidence-Based Complementary and AlternativeMedicine Volume 2015, Article ID 595480, 5 pages.
-Zan X et al., Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cellgrowth via cell cycle arrest and apoptosis, Int J Biol Macromol. 2015 May;76:242-53.
-Liu J et al., Anti-fatigue activities of polysaccharides extracted from Hericiumerinaceus., Exp Ther Med. 2015 Feb;9 (2):483-487.
-Wang K, et al., Erinacerins C-L, isoindolin-1-ones with-glucosidase inhibitory activityfrom cultures of the medicinal mushroom Hericium erinaceus, J Nat Prod. 2015 Jan23;78(1):146-54.
-Hou Y et al., Composition and antioxidant activity of water-soluble oligosaccharidesfrom Hericium erinaceus, Mol Med Rep. 2015 May;11(5):3794-9.
-Kobayashi H, et al., Effect of the replacement of aspartic acid/glutamic acid residueswith asparagine/glutamine residues in RNase He1 from Hericium erinaceus on inhibition ofhuman leukemia cell line proliferation., Biosci Biotechnol Biochem. 2015;79(2):211-7.